4.6 Article

Cardiovascular Health and Incident Cardiovascular Disease and Cancer The Women's Health Initiative

Journal

AMERICAN JOURNAL OF PREVENTIVE MEDICINE
Volume 50, Issue 2, Pages 236-240

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amepre.2015.07.039

Keywords

-

Funding

  1. National Heart, Lung, and Blood Institute, NIH, USDHHS [HHSN268201100046C, HHSN268201100001C, HHSN2 68201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]
  2. Pfizer, Inc.
  3. Pfizer
  4. Regeneron
  5. Amgen
  6. Medscape
  7. Amarin
  8. Astra-Zeneca
  9. Daiichi-Sankyo
  10. Esai
  11. Genetech
  12. Glaxo-Smith Kline
  13. Hoffman LaRoche
  14. Merck
  15. Regeneron/Sanofi
  16. Takeda
  17. Sanofi
  18. Novartis
  19. University of California San Francisco Smoking Cessation Learning Center

Ask authors/readers for more resources

Introduction: The American Heart Association's Simple 7 offers a practical public health conceptualization of cardiovascular health (CVH). CVH predicts incident cardiovascular disease (CVD) in younger populations, but has not been studied in a large, diverse population of aging postmenopausal women. The extent to which CVH predicts cancer in postmenopausal women is unknown. Methods: Multivariable Cox regression estimated hazard ratios and 95% CIs for the association between CVH and incident CVD, any cancer, and cancer subtypes (lung, colorectal, and breast) among 161,809 Women's Health Initiative observational study and clinical trial participants followed from 1993 through 2010. Data were analyzed in 2013. CVH score was characterized as the number (0 [worst] to 7 [best]) of the American Heart Association's ideal CVH behaviors and factors at baseline: smoking, BMI, physical activity, diet, total cholesterol, blood pressure, and fasting glucose. Results: Median follow-up was approximately 13 years. Fewer minorities and less educated women achieved ideal CVH, a common benchmark. In adjusted models, compared with women with the highest (best) CVH scores, those with the lowest (worst) CVH scores had nearly seven times the hazard of incident CVD (6.83, 95% CI = 5.83, 8.00) and 52% greater risk of incident cancer (1.52, 95% CI = 1.35, 1.72). Ideal CVH was most strongly inversely associated with lung cancer, then colorectal cancer, and then breast cancer. Conclusions: Lower ideal CVH is more common among minority and less educated postmenopausal women and predicts increased risk of CVD and cancer in this population, emphasizing the importance of prevention efforts among vulnerable older adults. (C) 2016 American Journal of Preventive Medicine

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available